FDA wants 2 months of safety data for Covid-19 vaccines in trials before considering authorization
5 years ago 1 min read
The FDA wants two months of follow-up data after volunteers get their second dose of Covid-19 vaccine as part of clinical trials testing potential coronavirus vaccines.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push